Changes in prescription practice of biological drugs in rheumatoid arthritis during the first three years of post-marketing use in Denmark and Norway: Criteria are becoming less stringent.

Elisabeth Hjardem, M.L. Hetland, Mikkel Østergaard, T.K. Kvien

OriginalsprogEngelsk
Publikationsdato2004
StatusUdgivet - 2004
BegivenhedAnn Rheum Dis -
Varighed: 18 jul. 2011 → …

Konference

KonferenceAnn Rheum Dis
Periode18/07/2011 → …

Citationsformater